表紙:世界の生殖補助医療技術(ART)市場:技術、製品、エンドユーザー、地域、国別(2020年版) - 市場の洞察、競争、および予測(2020年~2025年)
市場調査レポート
商品コード
926871

世界の生殖補助医療技術(ART)市場:技術、製品、エンドユーザー、地域、国別(2020年版) - 市場の洞察、競争、および予測(2020年~2025年)

Global Assisted Reproductive Technology (ART) Market - Analysis By Technology (IVF, Artificial Insemination, Others), Products, End User, By Region, By Country (2020 Edition): Market Insight, Competition and Forecast (2020-2025)

出版日: | 発行: Azoth Analytics | ページ情報: 英文 220 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.72円
世界の生殖補助医療技術(ART)市場:技術、製品、エンドユーザー、地域、国別(2020年版) - 市場の洞察、競争、および予測(2020年~2025年)
出版日: 2020年02月28日
発行: Azoth Analytics
ページ情報: 英文 220 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の生殖補助医療技術(ART)市場は、2019年に241億3,323万米ドルとなりました。同市場の成長要因には、初めての妊娠年齢の遅れによる合計特殊出生率(TFR)の低下、ストレスレベルの増加、汚染レベルの急増、アルコール消費と喫煙に伴う現代のライフスタイルなどによる不妊症の増加などが挙げられます。また、同性愛者カップルやシングルマザーの受け入れによるART使用の急増は、予測期間中の同市場の成長が牽引されると見込まれています。

当レポートは世界の生殖補助医療技術(ART)市場について調査しており、市場動向、成長および阻害要因、技術・エンドユーザー・製品タイプ・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 調査方法とエグゼクティブサマリー

  • 調査方法
  • エグゼクティブサマリー

第2章 戦略的提言

  • 低コスト技術の開発への焦点
  • 新興市場への焦点

第3章 製品の見通し

第4章 市場規模と予測

  • 市場規模、売上:2015~2025年

第5章 市場分析:技術別

  • 競合シナリオ
  • IVF
  • AI
  • その他

第6章 市場分析:エンドユーザー別

  • 競合シナリオ
  • 病院およびその他
  • 不妊治療クリニック

第7章 市場分析:製品タイプ別

  • 競合シナリオ
  • 医薬品
  • 機器
  • 消耗品
  • ソフトウェアとサービス

第8章 市場分析:地域別

  • 競合シナリオ

第9章 南北アメリカ

第10章 欧州

第11章 アジア太平洋地域

第12章 市場力学

  • 成長要因
  • 阻害要因
  • 市場の動向

第13章 市場の魅力

  • 技術別
  • エンドユーザー別
  • 製品タイプ別
  • 地域別

第14章 市場の主な開発

第15章 生殖補助医療のパイプライン

第16章 競合の見通しおよび市場占有率の分析

  • 大手グローバル企業の市場シェア
  • ARTを扱う競合企業の位置づけ

第17章 企業プロファイル

  • Irvine Scientific
  • Merck
  • Hamilton Thorne
  • Vitrolife
  • Monash IVF Group
  • INVO Bioscience
  • Cooper Surgical
  • Esco
  • Anecova
  • Nidacon International AB
図表

List of Figures

  • Figure 1: Global ART Market Size, By Value, 2015-2025 (USD Million)
  • Figure 2: Global Male Infertility Prevalence Rate, 2014 - 2017 (per 100k)
  • Figure 3: Global Female Infertility Prevalence Rate, 2014 - 2017 (per 100k)
  • Figure 4: Global Prevalence of Smoking among Persons Aged 15 and Above, 2013-2016 (In %)
  • Figure 5: Overweight Population aged 15+ in G7 countries, 2017 (%)
  • Figure 6: Global Total Fertility Rate, 2014 - 2017 (Births/Woman)
  • Figure 7: Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
  • Figure 8: Global ART Market, By Technology, year 2019 & 2025
  • Figure 9: Global Assisted Reproductive Technology Market - By IVF , By Value (USD Million), 2015-2025
  • Figure 10: Global Assisted Reproductive Technology Market - By AI , By Value (USD Million), 2015-2025
  • Figure 11: Global Assisted Reproductive Technology Market - By Others, By Value (USD Million), 2015-2025
  • Figure 12: Global ART Market, By End User, Year 2019 & 2025
  • Figure 13: Global Assisted Reproductive Technology Market - By Hospitals & Others, By Value (USD Million), 2015-2025
  • Figure 14: Global Assisted Reproductive Technology Market - By Fertility Clinics, By Value (USD Million), 2015-2025
  • Figure 15: Global ART Market, By Product Type, Year 2019 & 2025
  • Figure 16: Global Assisted Reproductive Technology Market - By Drugs, By Value (USD Million), 2015-2025
  • Figure 17: Global Assisted Reproductive Technology Market - By Instruments, By Value (USD Million), 2015-2025
  • Figure 18: Global Assisted Reproductive Technology Market - By Consumables, By Value (USD Million), 2015-2025
  • Figure 19: Global Assisted Reproductive Technology Market - By Software and Services, By Value (USD Million), 2015-2025
  • Figure 20: Regional ART Market, Year 2019 & 2025
  • Figure 21: Americas Assisted Reproductive Technology Market Size, By Value, 2015-2025 (USD Million)
  • Figure 22: Americas Male Infertility Prevalence Rate, 2014 - 2017 (per 100k)
  • Figure 23: Americas Female Infertility Prevalence Rate, 2014 - 2017 (per 100k)
  • Figure 24: Americas Prevalence of Smoking among Persons Aged 15 and Above, 2013-2016 (In %)
  • Figure 25: Americas Total Fertility Rate, 2014 - 2017 (Births/Woman)
  • Figure 26: Latin America and Caribbean Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
  • Figure 27: North America and Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
  • Figure 28: Americas Assisted Reproductive Technology Market - By Technology, By Value, 2015-2025 (USD Million)
  • Figure 29: Americas Assisted Reproductive Technology Market - By End User, By Value, 2015-2025 (USD Million)
  • Figure 30: Americas Assisted Reproductive Technology Market - By Product Type, By Value, 2015-2025 (USD Million)
  • Figure 31: Market Opportunity Chart of Americas Assisted Reproductive Technology Market - By Country, By Value (Year-2025)
  • Figure 32: Americas ART, By Country, Year 2019 & 2025
  • Figure 33: United States Assisted Reproductive Technology Market Size, By Value, 2015-2025 (USD Million)
  • Figure 34: United States Male Infertility Prevalence Rate, 2014 - 2017 (per 100k)
  • Figure 35: United States Female Infertility Prevalence Rate, 2014 - 2017 (per 100k)
  • Figure 36: United States Prevalence of Smoking among Persons Aged 15 and Above, 2013-2016 (In %)
  • Figure 37: United States Total Fertility Rate, 2014 - 2017 (Births/Woman)
  • Figure 38: United States Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
  • Figure 39: United States Assisted Reproductive Technology Market - By Technology, By Value, 2015-2025 (USD Million)
  • Figure 40: United States Assisted Reproductive Technology Market - By End User, By Value, 2015-2025 (USD Million)
  • Figure 41: United States Assisted Reproductive Technology Market - By Product Type, By Value, 2015-2025 (USD Million)
  • Figure 42: Canada Assisted Reproductive Technology Market Size, By Value, 2015-2025 (USD Million)
  • Figure 43: Canada Male Infertility Prevalence Rate, 2014 - 2017 (per 100k)
  • Figure 44: Canada Female Infertility Prevalence Rate, 2014 - 2017 (per 100k)
  • Figure 45: Canada Prevalence of Smoking among Persons Aged 15 and Above, 2013-2016 (In %)
  • Figure 46: Canada Total Fertility Rate, 2014 - 2017 (Births/Woman)
  • Figure 47: Canada Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
  • Figure 48: Canada Assisted Reproductive Technology Market - By Technology, By Value, 2015-2025 (USD Million)
  • Figure 49: Canada Assisted Reproductive Technology Market - By End User, By Value, 2015-2025 (USD Million)
  • Figure 50: Canada Assisted Reproductive Technology Market - By Product Type, By Value, 2015-2025 (USD Million)
  • Figure 51: Mexico Assisted Reproductive Technology Market Size, By Value, 2015-2025 (USD Million)
  • Figure 52: Mexico Male Infertility Prevalence Rate, 2014 - 2017 (per 100k)
  • Figure 53: Mexico Female Infertility Prevalence Rate, 2014 - 2017 (per 100k)
  • Figure 54: Mexico Prevalence of Smoking among Persons Aged 15 and Above, 2013-2016 (In %)
  • Figure 55: Mexico Total Fertility Rate, 2014 - 2017 (Births/Woman)
  • Figure 56: Mexico Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
  • Figure 57: Mexico Assisted Reproductive Technology Market - By Technology, By Value, 2015-2025 (USD Million)
  • Figure 58: Mexico Assisted Reproductive Technology Market - By End User, By Value, 2015-2025 (USD Million)
  • Figure 59: Mexico Assisted Reproductive Technology Market - By Product Type, By Value, 2015-2025 (USD Million)
  • Figure 60: Brazil Assisted Reproductive Technology Market Size, By Value, 2015-2025 (USD Million)
  • Figure 61: Brazil Male Infertility Prevalence Rate, 2014 - 2017 (per 100k
  • Figure 62: Brazil Female Infertility Prevalence Rate, 2014 - 2017 (per 100k)
  • Figure 63: Brazil Prevalence of Smoking among Persons Aged 15 and Above, 2013-2016 (In %)
  • Figure 64: Brazil Total Fertility Rate, 2014 - 2017 (Births/Woman)
  • Figure 65: Brazil Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
  • Figure 66: Brazil Assisted Reproductive Technology Market - By Technology, By Value, 2015-2025 (USD Million)
  • Figure 67: Brazil Assisted Reproductive Technology Market - By End User, By Value, 2015-2025 (USD Million)
  • Figure 68: Brazil Assisted Reproductive Technology Market - By Product Type, By Value, 2015-2025 (USD Million)
  • Figure 69: Europe Assisted Reproductive Technology Market Size, By Value, 2015-2025 (USD Million)
  • Figure 70: Europe Male Infertility Prevalence Rate, 2014 - 2017 (per 100k)
  • Figure 71: Europe Female Infertility Prevalence Rate, 2014 - 2017 (per 100k)
  • Figure 72: Europe Prevalence of Smoking among Persons Aged 15 and Above, 2013-2016 (In %)
  • Figure 73: European Union Total Fertility Rate, 2014 - 2017 (Births/Woman)
  • Figure 74: Europe Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
  • Figure 75: Europe total fertility rate(children/woman),2017
  • Figure 76: Europe Assisted Reproductive Technology Market - By Technology, By Value, 2015-2025 (USD Million)
  • Figure 77: Europe Assisted Reproductive Technology Market - By End User, By Value, 2015-2025 (USD Million)
  • Figure 78: Europe Assisted Reproductive Technology Market - By Product Type, By Value, 2015-2025 (USD Million)
  • Figure 79: Market Opportunity Chart of Europe Assisted Reproductive technology Market - By Country, By Value, 2025
  • Figure 80: Europe ART, By Country, Year 2019 & 2025
  • Figure 81: Germany Assisted Reproductive Technology Market Size, By Value, 2015-2025 (USD Million)
  • Figure 82: Germany Male Infertility Prevalence Rate, 2014 - 2017 (per 100k)
  • Figure 83: Germany Female Infertility Prevalence Rate, 2014 - 2017 (per 100k)
  • Figure 84: Germany Prevalence of Smoking among Persons Aged 15 and Above, 2013-2016 (In %)
  • Figure 85: Germany Total Fertility Rate, 2014 - 2017 (Births/Woman)
  • Figure 86: Germany Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
  • Figure 87: Germany Assisted Reproductive Technology Market - By Technology, By Value, 2015-2025 (USD Million)
  • Figure 88: Germany Assisted Reproductive Technology Market - By End User, By Value, 2015-2025 (USD Million)
  • Figure 89: Germany Assisted Reproductive Technology Market - By Product Type, By Value, 2015-2025 (USD Million)
  • Figure 90: United Kingdom Assisted Reproductive Technology Market Size, By Value, 2015-2025 (USD Million)
  • Figure 91: UK Male Infertility Prevalence Rate, 2014 - 2017 (per 100k)
  • Figure 92: UK Female Infertility Prevalence Rate, 2014 - 2017 (per 100k)
  • Figure 93: UK Prevalence of Smoking among Persons Aged 15 and Above, 2013-2016 (In %)
  • Figure 94: UK Total Fertility Rate, 2014 - 2017 (Births/Woman)
  • Figure 95: United Kingdom Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
  • Figure 96: UK Assisted Reproductive Technology Market - By Technology, By Value, 2015-2025 (USD Million)
  • Figure 97: UK Assisted Reproductive Technology Market - By End User, By Value, 2015-2025 (USD Million)
  • Figure 98: UK Assisted Reproductive Technology Market - By Product Type, By Value, 2015-2025 (USD Million)
  • Figure 99: Italy Assisted Reproductive Technology Market Size, By Value, 2015-2025 (USD Million)
  • Figure 100: Italy Male Infertility Prevalence Rate, 2014 - 2017 (per 100k)
  • Figure 101: Italy Female Infertility Prevalence Rate, 2014 - 2017 (per 100k)
  • Figure 102: Italy Prevalence of Smoking among Persons Aged 15 and Above, 2013-2016 (In %)
  • Figure 103: Italy Total Fertility Rate, 2014 - 2017 (Births/Woman)
  • Figure 104: Italy Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
  • Figure 105: Italy Assisted Reproductive Technology Market - By Technology, By Value, 2015-2025 (USD Million)
  • Figure 106: Italy Assisted Reproductive Technology Market - By End User, By Value, 2015-2025 (USD Million)
  • Figure 107: Italy Assisted Reproductive Technology Market - By Product Type, By Value, 2015-2025 (USD Million)
  • Figure 108: Asia Pacific Assisted Reproductive Technology Market Size, By Value, 2015-2025 (USD Million)
  • Figure 109: Asia Pacific Male Infertility Prevalence Rate, 2014 - 2017 (per 100k)
  • Figure 110: Asia Pacific Female Infertility Prevalence Rate, 2014 - 2017 (per 100k)
  • Figure 111: Asia Pacific Prevalence of Smoking among Persons Aged 15 and Above, 2013-2016 (In %)
  • Figure 112: Asia Pacific Total Fertility Rate, 2014 - 2017 (Births/Woman)
  • Figure 113: Asia Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
  • Figure 114: Asia Pacific Assisted Reproductive Technology Market - By Technology, By Value, 2015-2025 (USD Million)
  • Figure 115: Asia Pacific Assisted Reproductive Technology Market - By End User, By Value, 2015-2025 (USD Million)
  • Figure 116: Asia Pacific Assisted Reproductive Technology Market - By Product Type, By Value, 2015-2025 (USD Million)
  • Figure 117: Market Opportunity Chart of Asia Pacific ART Market - By Country, By Value, 2025
  • Figure 118: Asia Pacific ART, By Country, Year 2019 & 2025
  • Figure 119: China Assisted Reproductive Technology Market Size, By Value, 2015-2025 (USD Million)
  • Figure 120: China Male Infertility Prevalence Rate, 2014 - 2017 (per 100k)
  • Figure 121: China Female Infertility Prevalence Rate, 2014 - 2017 (per 100k)
  • Figure 122: China Prevalence of Smoking among Persons Aged 15 and Above, 2013-2016 (In %)
  • Figure 123: China Total Fertility Rate, 2014 - 2017 (Births/Woman)
  • Figure 124: China Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
  • Figure 125: China Assisted Reproductive Technology Market - By Technology, By Value, 2015-2025 (USD Million)
  • Figure 126: China Assisted Reproductive Technology Market - By End User, By Value, 2015-2025 (USD Million)
  • Figure 127: China Assisted Reproductive Technology Market - By Product Type, By Value, 2015-2025 (USD Million)
  • Figure 128: Japan Assisted Reproductive Technology Market Size, By Value, 2015-2025 (USD Million)
  • Figure 129: Japan Male Infertility Prevalence Rate, 2014 - 2017 (per 100k)
  • Figure 130: Japan Female Infertility Prevalence Rate, 2014 - 2017 (per 100k)
  • Figure 131: Japan Prevalence of Smoking among Persons Aged 15 and Above, 2013-2016 (In %)
  • Figure 132: Japan Total Fertility Rate, 2014 - 2017 (Births/Woman)
  • Figure 133: Japan Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
  • Figure 134: Japan Assisted Reproductive Technology Market - By Technology, By Value, 2015-2025 (USD Million)
  • Figure 135: Japan Assisted Reproductive Technology Market - By End User, By Value, 2015-2025 (USD Million)
  • Figure 136: Japan Assisted Reproductive Technology Market - By Product Type, By Value, 2015-2025 (USD Million)
  • Figure 137: India Assisted Reproductive Technology Market Size, By Value, 2015-2025 (USD Million)
  • Figure 138: India Male Infertility Prevalence Rate, 2014 - 2017 (per 100k)
  • Figure 139: India Female Infertility Prevalence Rate, 2014 - 2017 (per 100k)
  • Figure 140: India Prevalence of Smoking among Persons Aged 15 and Above, 2013-2016 (In %)
  • Figure 141: India Total Fertility Rate, 2014 - 2017 (Births/Woman)
  • Figure 142: India Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
  • Figure 143: India Assisted Reproductive Technology Market - By Technology, By Value, 2015-2025 (USD Million)
  • Figure 144: India Assisted Reproductive Technology Market - By End User, By Value, 2015-2025 (USD Million)
  • Figure 145: India Assisted Reproductive Technology Market - By Product Type, By Value, 2015-2025 (USD Million)
  • Figure 146: Market Attractiveness Chart of Global ART Market - By Technology Segment, 2025
  • Figure 147: Market Attractiveness Chart of Global ART Market - By End User, 2025
  • Figure 148: Market Attractiveness Chart of Global ART Market - By Product Type, By Value, 2025
  • Figure 149: Market Attractiveness Chart of Global ART Market - By Region, By Value, 2025
  • Figure 150: Market Share of Leading Global Assisted Reproductive Technology Companies, 2018 (In %)
  • Figure 151: Competitive Positions of companies dealing in Assisted Reproductive Technology (2018)
  • Figure 152: Merck Revenue, 2014-2018 (In USD Million)
  • Figure 153: Merck Revenue, By Region, 2017 (In %)
  • Figure 154: Merck Revenue, By Region, 2018 (In %)
  • Figure 155: Merck Revenue, By Business Segment, 2017 (In %)
  • Figure 156: Merck Revenue, By Business Segment, 2018 (In %)
  • Figure 157: Hamilton Thorne Sales Revenue, 2014 - 2018 (In USD Million)
  • Figure 158: Hamilton Thorne Net Income, 2014 - 2018 (In USD Million)
  • Figure 159: Hamilton Thorne Segment Sales Revenue, 2017 (In %)
  • Figure 160: Hamilton Thorne Segment Sales Revenue, 2018 (In %)
  • Figure 161: Vitrolife Net Sales, 2014 - 2018 (In USD Million)
  • Figure 162: Vitrolife Net Income, 2014-2018(In USD Million)
  • Figure 163: Vitrolife Net Sales, By Region, 2018 (In %)
  • Figure 164: Vitrolife Net Sales, By Business Sector, 2018 (In %)
  • Figure 165: Vitrolife Net Sales By Products and Services, 2018 (In %)
  • Figure 166: Monash IVF Group Revenue, 2015 - 2019 (In USD Million)
  • Figure 167: Monash IVF Group Revenue, By Region, 2018 (In %)
  • Figure 168: Monash IVF Group Revenue, By Region, 2019 (In %)
  • Figure 169: INVO Bioscience Revenue, 2014 - 2018 (In USD Thousands)
  • Figure 170: INVO Bioscience, Net Loss, 2014-2018(In Thousands)
  • Figure 171: Cooper Companies Inc. & Subsidiaries, Net Sales 2015-2019 (In USD Million)
  • Figure 172: Cooper Surgical Net Sales 2015-2019(In USD Million)
  • Figure 173: Cooper Surgical Net Sales By Category, 2019, (%)
  • Figure 174: Cooper Surgical Net Sales By Category, 2018, (%)

List of Tables

Table A: Fertility Drugs Used during Assisted Reproductive Treatment

Table B: Global Market Share Analysis of Companies

目次

Executive Summary

Global Assisted Reproductive Technology Market was valued at USD 24133.23 Million in the year 2019. Delay in age of first time pregnancy has led to lowering of total fertility rate (TFR) globally. Growing stress levels, escalation in pollution levels, modern lifestyle with increase in alcohol consumption and smoking are all cumulatively leading to increase in male and female infertility. Acceptance of homosexual couples and single mothers surging in number for use of ART are anticipated to lead market growth in the forecast period of 2020-2025.

Various techniques such as In Vitro fertilization (IVF), Artificial Insemination, Zygote Intra-fallopian transfer (ZIFT), Gamete Intra-fallopian Transfer (GIFT) are used according to need of the patient. In Vitro fertilization is considered as Gold standard for ART due to high success rate for embryo transfer and increase in live birth rates. Drugs such as orals and hormones which are injectable, are used prior to ART treatment and also during the treatment to prepare the body. Drugs market is estimated to grow heavily with elaborate pipeline. Moreover, INVOcell and Anecova have developed In vivo ART devices, which are likely to facilitate market growth in the forecast period.

Among the regions, Asia Pacific, followed by Europe and Americas, will experience the highest growth rate owing to decrease in male and female fertility.

Scope of the Report

  • The report analyses Assisted Reproductive Technology Market at global, regional and country-levels.
  • The report analyses Assisted Reproductive Technology Market By Technology (In vitro Fertilization, Artificial Insemination, Others).
  • The report assesses the Assisted Reproductive Technology Market By End User (Hospitals, Fertility clinics).
  • The report assesses the Assisted Reproductive Technology Market By Products (Consumables, Instruments, Software and Services, Drugs).
  • The Global Assisted Reproductive Technology Market has been analysed By Region (Americas, Europe, Asia Pacific) and By Country (USA, Canada, Brazil, Mexico, China, Japan, India, UK, Germany, Italy).
  • The key insights of the report have been presented through the frameworks of Key developments and drug pipeline phases. Also, the attractiveness of the market has been presented by Technology, End User, Products and Region. Additionally, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
  • The companies analysed in the report include Merck, Hamilton Thorne, Cooper Surgical, Nidacon International AB, Anecova, Esco, INVO Bioscience, Monash IVF Group, Irvine Scientific.
  • The report presents the analysis of Assisted Reproductive Technology market for the historical period of 2015-2019 and the forecast period of 2020-2025.

Key Target Audience

  • Pharmaceutical Firms
  • IVF Clinics and Hospitals
  • Consulting and Advisory Firms
  • Medical Practitioners

Table of Contents

1. Research Methodology and Executive Summary

  • 1.1 Research Methodology
  • 1.2 Executive Summary

2. Strategic Recommendations

  • 2.1 Focus on Development of Low Cost Technology
  • 2.2 Focus on Emerging Markets

3. Assisted Reproductive Technology Market: Product Outlook

4. Global Assisted Reproductive Technology Market: Sizing and Forecast

  • 4.1 Market Size, By Value, Year 2015-2025

5. Global ART Market Segmentation - By Technology

  • 5.1 Competitive Scenario of Global ART: By Technology
  • 5.2 IVF - Market Size and Forecast (2015-2025)
  • 5.3 AI - Market Size and Forecast (2015-2025)
  • 5.4 Others - Market Size and Forecast (2015-2025)

6. Global ART Market Segmentation - By End User

  • 6.1 Competitive Scenario of Global ART: By End User
  • 6.2 Hospitals & Others - Market Size and Forecast (2015-2025)
  • 6.3 Fertility Clinics - Market Size and Forecast (2015-2025)

7. Global ART Market Segmentation - By Product Type

  • 7.1 Competitive Scenario of Global ART: By Product Type
  • 7.2 Drugs - Market Size and Forecast (2015-2025)
  • 7.3 Instruments - Market Size and Forecast (2015-2025)
  • 7.4 Consumables - Market Size and Forecast (2015-2025)
  • 7.5 Software & Services - Market Size and Forecast (2015-2025)

8. Global Assisted Reproductive Technology Market: Regional Analysis

  • 8.1 Competitive Scenario of Global ART: By Region

9. Americas ART Market: Segmentation By Technology, End User, Product Type (2015-2025)

  • 9.1 Americas ART Market: Size and Forecast (2015-2025), By Value
  • 9.2 Americas ART Market - Prominent Companies
  • 9.3 Market Segmentation By Technology (IVF, AI and Others)
  • 9.4 Market Segmentation By End User (Hospitals & Others, Fertility Clinics)
  • 9.5 Market Segmentation By Product Type (Consumables, Instruments, Drugs, Software & Services)
  • 9.6 Americas ART Market: Country Analysis
  • 9.7 Market Opportunity Chart of Americas ART Market - By Country, By Value, 2025
  • 9.8 Competitive Scenario of Americas ART: By Country, Year 2019 & 2025
  • 9.9 United States ART Market: Size and Forecast (2015-2025), By Value
  • 9.10 United States ART Market Segmentation - By Technology, By End User, By Product Type
  • 9.11 Canada ART Market: Size and Forecast (2015-2025), By Value
  • 9.12 Canada ART Market Segmentation - By Technology, By End User, By Product Type
  • 9.13 Mexico ART Market: Size and Forecast (2015-2025), By Value
  • 9.14 Mexico ART Market Segmentation - By Technology, By End User, By Product Type
  • 9.15 Brazil ART Market: Size and Forecast (2015-2025), By Value
  • 9.16 Brazil ART Market Segmentation - By Technology, By End User, By Product Type

10. Europe ART Market: Segmentation By Technology, End User, Product Type (2015-2025)

  • 10.1 Europe ART Market: Size and Forecast (2015-2025), By Value
  • 10.2 Europe ART Market - Prominent Companies
  • 10.3 Market Segmentation By Technology (IVF, AI and Others)
  • 10.4 Market Segmentation By End User (Hospitals & Others, Fertility Clinics)
  • 10.5 Market Segmentation By Product Type (Consumables, Instruments, Drugs, Software & Services)
  • 10.6 Europe ART Market: Country Analysis
  • 10.7 Market Opportunity Chart of Europe ART Market - By Country, By Value, 2025
  • 10.8 Competitive Scenario of Europe ART: By Country, Year 2019 & 2025
  • 10.9 Germany ART Market: Size and Forecast (2015-2025), By Value
  • 10.10 Germany ART Market Segmentation - By Technology, By End User, By Product Type
  • 10.11 United Kingdom ART Market: Size and Forecast (2015-2025), By Value
  • 10.12 United Kingdom ART Market Segmentation - By Technology, By End User, By Product Type
  • 10.13 Italy ART Market: Size and Forecast (2015-2025), By Value
  • 10.14 Italy ART Market Segmentation - By Technology, By End User, By Product Type

11. Asia Pacific ART Market: Segmentation By Technology, End User, Product Type (2015-2025)

  • 11.1 Asia Pacific ART Market: Size and Forecast (2015-2025), By Value
  • 11.2 Asia Pacific ART Market - Prominent Companies
  • 11.3 Market Segmentation By Technology (IVF, AI and Others)
  • 11.4 Market Segmentation By End User (Hospitals & Others, Fertility Clinics)
  • 11.5 Market Segmentation By Product Type (Consumables, Instruments, Drugs, Software & Services)
  • 11.6 Asia Pacific ART Market: Country Analysis
  • 11.7 Market Opportunity Chart of Asia Pacific ART Market - By Country, By Value, 2025
  • 11.8 Competitive Scenario of Asia Pacific ART: By Country, Year 2019 & 2025
  • 11.9 China ART Market: Size and Forecast (2015-2025), By Value
  • 11.10 China ART Market Segmentation - By Technology, By End User, By Product Type
  • 11.11 Japan ART Market: Size and Forecast (2015-2025), By Value
  • 11.12 Japan ART Market Segmentation - By Technology, By End User, By Product Type
  • 11.13 India ART Market: Size and Forecast (2015-2025), By Value
  • 11.14 India ART Market Segmentation - By Technology, By End User, By Product Type

12. Global Assisted Reproductive Technology Market Dynamics

  • 12.1 Drivers
  • 12.2 Restraints
  • 12.3 Trends

13. Market Attractiveness

  • 13.1 Market Attractiveness Chart of Global ART Market - By Technology Segment, 2025
  • 13.2 Market Attractiveness Chart of Global ART Market - By End User Segment, 2025
  • 13.3 Market Attractiveness Chart of Global ART Market - By Product Type Segment, 2025
  • 13.4 Market Attractiveness Chart of Global ART Market - By Region Segment, 2025

14. Key Developments in Assisted Reproductive Technology Market

15. Assisted Reproductive Technology Pipeline

16. Competitive Landscape and Market Share Analysis

  • 16.1 Market Share of Leading Global Companies
  • 16.2 Competitive Position of companies dealing in ART

17. Company Analysis

  • 17.1 Irvine Scientific
  • 17.2 Merck
  • 17.3 Hamilton Thorne
  • 17.4 Vitrolife
  • 17.5 Monash IVF Group
  • 17.6 INVO Bioscience
  • 17.7 Cooper Surgical
  • 17.8 Esco
  • 17.9 Anecova
  • 17.10 Nidacon International AB